High incidence of depression and sleep disturbances associated with PegIFN-alpha-2b/ribivirin therapy for hepatitis C in routine clinical practice

Finkelman, David
September 2003
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS85
Academic Journal
An abstract of the article "High Incidence of Depression and Sleep Disturbances Associated with PegIFN-Alpha-2b/Ribivirin Therapy for Hepatitis C in Routine Clinical Practice," by David Finkelman is presented.


Related Articles

  • Review of patient-reported outcome measures in chronic hepatitis C. Kleinman, Leah; Mannix, Sally; Yong Yuan; Kummer, Shannon; L¨Italien, Gilbert; Revicki, Dennis // Health & Quality of Life Outcomes;2012, Vol. 10 Issue 1, p92 

    Background: Chronic hepatitis C (CHC) and its treatment are associated with a variety of patient-reported symptoms and impacts. Some CHC symptoms and impacts may be difficult to evaluate through objective clinical testing, and more easily measured through patient self-report. This literature...

  • Neuropsychiatric and Psychosocial Issues of Patients With Hepatitis C Infection: A Selective Literature Review. Modabbernia, Amirhossein; Poustchi, Hossein; Malekzadeh, Reza // Hepatitis Monthly;Jan2013, Vol. 13 Issue 1, p1 

    Context: We briefly reviewed the evidence on the association of hepatitis C (HCV) infection with several aspects of mental and psychosocial health. Evidence Acquisition: Medline was searched with appropriate keywords. The primary sources were the systematic reviews. If systematic reviews were...

  • Hepatitis C. Gully, Paul R.; Tepper, Martin L. // CMAJ: Canadian Medical Association Journal;05/15/97, Vol. 156 Issue 10, p1427 

    Focuses on hepatitis C in Canada. Epidemiology; Natural history; Management of the disease.

  • Hepatitis C virus infection: Prevalence, diagnosis and treatment. Wade, William E. // Drug Topics;10/7/96 Supplement, Vol. 140 Issue 19, p18S 

    Discusses the course of Hepatitis C and its treatment. Epidemiology of the disease; Mechanism of hepatocellular damage it causes; Diagnostic procedures done; Pathophysiology of Hepatitis C; Pharmacokinetics, adverse effects and precautions of interferon; Drug to drug interactions with...

  • Hunt begins for patients suspected of having hepatitis C. Court, Claudia // BMJ: British Medical Journal (International Edition);1/21/95, Vol. 310 Issue 6973, p146 

    Reports on the efforts of health officials to trace former hospital patients who received blood transfusions before September 1991 due to the possibility of having been infected with hepatitis C virus. Recommendation of the Advisory Committee on the Microbiological safety of Blood and Tissues...

  • Hepatitis C infection. Wetherbee, Roger E. // Cortlandt Forum;6/25/95, Vol. 8 Issue 6, p170 

    Responds to questions about hepatitis C infection. Hepatitis C prevalence in North America and Europe; Characteristics of typical patients; Contracting of hepatitis C from a blood transfusion.

  • SURPRISE RISK FOR TYPE 2. P.R. // Prevention;Jul2002, Vol. 54 Issue 7, p161 

    Reports that people who have hepatitis C virus have three times the chance that they will also have type 2 diabetes.

  • Hepatitis C Virus Infection Trends in Italy. Lavanchy, Daniel // Hepatitis Monthly;2012, Vol. 12 Issue 1, p46 

    A letter to the editor is presented in response to the article "Hepatitis C Virus Infection Trends in Italy" by G. La Torre, M. R. Gualano, and L. Semyonov in the November 2011 issue.

  • Update on an epidemic. Doheny, Kathleen // Shape;Sep98, Vol. 18 Issue 1, p64 

    Presents information on the viral infection hepatitis C, which affects the liver and can progress to a life-threatening disease. Estimated number of deaths which the illness causes annually in the United States; Approval of the combination drug, interferon-ribavirin, to treat chronic hepatitis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics